Table 4.

Distribution of individual case safety reports (ICSRs) by preferred terms (PTs) and outcome

	Morphea	Scleroderma	Scleroderma renal crisis	Scleroderma-like reaction	Systemic scleroderma
Favorable, n (%)	12 (52)	6 (30)	1 (50)	3 (25)	6 (33)
Unfavorable, n (%)	3 (13)	4 (20)	–	5 (42)	7 (39)
Not available, n (%)	8 (35)	10 (50)	1 (50)	4 (33)	5 (28)
Total ICSRs/PTs	23 (100)	20 (100)	2 (100)	12 (100)	18 (100)

Favorable outcome: recovering/resolving; unfavorable outcome: not recovered/not resolved; death